Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Cocaine Dependence
Interventions
DRUG

Adderall-ER

MAS-ER 60mg/day

DRUG

Topiramate

Topiramate 100 mg bid.

OTHER

Placebo

Placebo

Trial Locations (2)

10032

STARS, New York

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT01811940 - Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence | Biotech Hunter | Biotech Hunter